Intellectual Property India Publishes Patent Application for 'An Adenosine Analogue Compound Against Severe Acute Respiratory Syndrome-Coronavirus-2' Filed by Sharda University

MUMBAI, India, Dec. 13 -- Intellectual Property India has published a patent application (202411032512 A) filed by Sharda University, Greater Noida, Uttar Pradesh, on Oct. 24, 2024, for 'an adenosine analogue compound against severe acute respiratory syndrome-coronavirus-2.'

Inventor(s) include Buvvaji, Shareef Mohammed; Joshi, Vinod; Khaneja, Poorna; Angel, Annette; Angel, Bennet; and Joshi, Ramesh.

The application for the patent was published on Dec. 12, under issue no. 50/2025.

According to the abstract released by the Intellectual Property India: "The present invention provides an adenosine analogue compound against Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2). Particularly, the present invention provides an adenosine...